Loading...
Anti-erbB2 treatment induces cardiotoxicity by interfering with cell survival pathways
INTRODUCTION: Cardiac dysfunction is among the serious side effects of therapy with recombinant humanized anti-erbB2 monoclonal antibody. The antibody blocks ErbB-2, a receptor tyrosine kinase and co-receptor for other members of the ErbB and epidermal growth factor families, which is over-expressed...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2006
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1779483/ https://ncbi.nlm.nih.gov/pubmed/16839426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr1523 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|